Jazz Pharmaceuticals (JAZZ) Q4 2023 Earnings

28FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
3.95
4.36
4.77
5.18

Details

Expected EPS
5.184712
Actual EPS
5.02
Surprise EPS
-0.16
Surprise Percent
+3.18%

Description

Jazz Pharmaceuticals (JAZZ) has reported earnings of 5.02 per share for Q4 2023.

0 Comments

Share your thoughts